» Articles » PMID: 37647980

Manufacturing Pharmaceutical Mini-tablets for Pediatric Patients Using Drop-on-demand Printing

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2023 Aug 30
PMID 37647980
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmaceutical industry has traditionally manufactured medicines in a limited range of dose strengths, with an emphasis on addressing the needs of the largest patient subgroups. This has disadvantaged smaller patient subsets, such as children, who often cannot find drug products in dosage levels suitable for their requirements. In recent years, development of pharmaceutical mini-tablets has emerged as an attractive solution to this problem. These are small-size dosages that offer attractive features such as flexible and personalized drug dosing, ease of swallowing, and tailored drug release, making them an excellent choice for administering medicines to children. This study presents a novel technique for manufacturing pharmaceutical mini-tablets, using a drop-on-demand (DoD) printing system. In this method, a DoD system is used to generate precise droplets of a melt-based formulation, which are then captured and solidified in an inert solvent bath to produce individual mini-tablets. The study also evaluates the performance of this technique for various formulations, and quantifies two critical quality attributes (CQAs) of the resulting mini-tablets: content uniformity and dissolution behavior. The findings demonstrate that the manufactured mini-tablets can meet regulatory specifications for both CQAs, and that their release profiles can be customized by modifying the excipients used. The study also discusses promising areas of application and limitations of this technique.

Citing Articles

Pediatric Formulations Developed by Extrusion-Based 3D Printing: From Past Discoveries to Future Prospects.

Ianno V, Vurpillot S, Prillieux S, Espeau P Pharmaceutics. 2024; 16(4).

PMID: 38675103 PMC: 11054634. DOI: 10.3390/pharmaceutics16040441.


Quality by Design Considerations for Drop-on-Demand Point-of-Care Pharmaceutical Manufacturing of Precision Medicine.

Forbes T, Gillen J, Feeney W, Ho J Mol Pharm. 2024; 21(7):3268-3280.

PMID: 38661480 PMC: 11262155. DOI: 10.1021/acs.molpharmaceut.4c00032.


Revolutionizing Three-Dimensional Printing: Enhancing Quality Assurance and Point-of-Care Integration through Instrumentation.

Suarez-Gonzalez J, Diaz-Torres E, Monzon-Rodriguez C, Santovena-Estevez A, Farina J Pharmaceutics. 2024; 16(3).

PMID: 38543302 PMC: 10974933. DOI: 10.3390/pharmaceutics16030408.


Developing a Modular Continuous Drug Product Manufacturing System with Real Time Quality Assurance for Producing Pharmaceutical Mini-Tablets.

Sundarkumar V, Wang W, Mills M, Oh S, Nagy Z, Reklaitis G J Pharm Sci. 2023; 113(4):937-947.

PMID: 37788791 PMC: 10947937. DOI: 10.1016/j.xphs.2023.09.024.

References
1.
Hirshfield L, Giridhar A, Taylor L, Harris M, Reklaitis G . Dropwise additive manufacturing of pharmaceutical products for solvent-based dosage forms. J Pharm Sci. 2013; 103(2):496-506. DOI: 10.1002/jps.23803. View

2.
Daly R, Harrington T, Martin G, Hutchings I . Inkjet printing for pharmaceutics - A review of research and manufacturing. Int J Pharm. 2015; 494(2):554-567. DOI: 10.1016/j.ijpharm.2015.03.017. View

3.
Chen H, Wang C, Liu S, Sun C . Development of piroxicam mini-tablets enabled by spherical cocrystallization. Int J Pharm. 2020; 590:119953. DOI: 10.1016/j.ijpharm.2020.119953. View

4.
Icten E, Purohit H, Wallace C, Giridhar A, Taylor L, Nagy Z . Dropwise additive manufacturing of pharmaceutical products for amorphous and self emulsifying drug delivery systems. Int J Pharm. 2017; 524(1-2):424-432. DOI: 10.1016/j.ijpharm.2017.04.003. View

5.
Kadu P, Kushare S, Thacker D, Gattani S . Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS). Pharm Dev Technol. 2010; 16(1):65-74. DOI: 10.3109/10837450903499333. View